{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:34:53Z","timestamp":1762544093017,"version":"3.37.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["KK.01.1.1.01.0008"],"award-info":[{"award-number":["KK.01.1.1.01.0008"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["International Orthopaedics (SICOT)"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00264-024-06389-w","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T04:22:38Z","timestamp":1733113358000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic inhibition of bone morphogenetic protein 1.3 as a possible treatment for laminin-related congenital muscular dystrophy"],"prefix":"10.1007","volume":"49","author":[{"given":"Ivona","family":"Matic Jelic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Stokovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Ivanjko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Pecina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Kufner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Bordukalo Niksic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slobodan","family":"Vukicevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"6389_CR1","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1212\/WNL.0000000000001416","volume":"84","author":"PB Kang","year":"2015","unstructured":"Kang PB, Morrison L, Iannaccone ST, Graham RJ, Bonnemann CG, Rutkowski A, Hornyak J, Wang CH, North K, Oskoui M, Getchius TS, Cox JA, Hagen EE, Gronseth G, Griggs RC, Guideline Development Subcommittee of the American Academy of N, the Practice Issues Review Panel of the American Association of N and Electrodiagnostic M (2015) Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology 84:1369\u20131378. https:\/\/doi.org\/10.1212\/WNL.0000000000001416","journal-title":"Neurology"},{"key":"6389_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/TACG.S187481","volume":"12","author":"Q Nguyen","year":"2019","unstructured":"Nguyen Q, Lim KRQ, Yokota T (2019) Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-alpha2 chain-deficient congenital muscular dystrophy. Appl Clin Genet 12:113\u2013130. https:\/\/doi.org\/10.2147\/TACG.S187481","journal-title":"Appl Clin Genet"},{"key":"6389_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/bs.ctm.2015.05.002","volume":"76","author":"M Durbeej","year":"2015","unstructured":"Durbeej M (2015) Laminin-alpha2 chain-deficient congenital muscular dystrophy: pathophysiology and development of treatment. Curr Top Membr 76:31\u201360. https:\/\/doi.org\/10.1016\/bs.ctm.2015.05.002","journal-title":"Curr Top Membr"},{"key":"6389_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0960-8966(01)00232-2","volume":"11","author":"AM Connolly","year":"2001","unstructured":"Connolly AM, Keeling RM, Mehta S, Pestronk A, Sanes JR (2001) Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin\/utrophin-, and laminin alpha2-deficient mice. Neuromuscul Disord 11:703\u2013712. https:\/\/doi.org\/10.1016\/s0960-8966(01)00232-2","journal-title":"Neuromuscul Disord"},{"key":"6389_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/cam.22618","volume":"7","author":"J Holmberg","year":"2013","unstructured":"Holmberg J, Durbeej M (2013) Laminin-211 in skeletal muscle function. Cell Adh Migr 7:111\u2013121. https:\/\/doi.org\/10.4161\/cam.22618","journal-title":"Cell Adh Migr"},{"key":"6389_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/adc.80.6.542","volume":"80","author":"J Philpot","year":"1999","unstructured":"Philpot J, Bagnall A, King C, Dubowitz V, Muntoni F (1999) Feeding problems in merosin deficient congenital muscular dystrophy. Arch Dis Child 80:542\u2013547. https:\/\/doi.org\/10.1136\/adc.80.6.542","journal-title":"Arch Dis Child"},{"key":"6389_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/B978-0-12-382219-2.00191-5","volume-title":"Handbook of proteolytic enzymes","author":"E Kessler","year":"2013","unstructured":"Kessler E (2013) Procollagen C-Endopeptidase. In: Rawlings ND, Salvesen G (eds) Handbook of proteolytic enzymes, vol 1, 3rd edn. Elsevier, London, UK, pp 916\u2013932","edition":"3"},{"key":"6389_CR8","doi-asserted-by":"publisher","first-page":"18045","DOI":"10.1074\/jbc.M211448200","volume":"278","author":"N Hartigan","year":"2003","unstructured":"Hartigan N, Garrigue-Antar L, Kadler KE (2003) Bone morphogenetic protein-1 (BMP-1). Identification of the minimal domain structure for procollagen C-proteinase activity. J Biol Chem 278:18045\u201318049. https:\/\/doi.org\/10.1074\/jbc.M211448200","journal-title":"J Biol Chem"},{"key":"6389_CR9","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1128\/MCB.23.13.4428-4438.2003","volume":"23","author":"WN Pappano","year":"2003","unstructured":"Pappano WN, Steiglitz BM, Scott IC, Keene DR, Greenspan DS (2003) Use of Bmp1\/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1\/tolloid-like metalloproteinases. Mol Cell Biol 23:4428\u20134438. https:\/\/doi.org\/10.1128\/MCB.23.13.4428-4438.2003","journal-title":"Mol Cell Biol"},{"key":"6389_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00264-013-2201-1","volume":"38","author":"S Vukicevic","year":"2014","unstructured":"Vukicevic S, Oppermann H, Verbanac D, Jankolija M, Popek I, Curak J, Brkljacic J, Pauk M, Erjavec I, Francetic I, Dumic-Cule I, Jelic M, Durdevic D, Vlahovic T, Novak R, Kufner V, Bordukalo Niksic T, Kozlovic M, Banic Tomisic Z, Bubic-Spoljar J, Bastalic I, Vikic-Topic S, Peric M, Pecina M, Grgurevic L (2014) The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing. Int Orthop 38:635\u2013647. https:\/\/doi.org\/10.1007\/s00264-013-2201-1","journal-title":"Int Orthop"},{"key":"6389_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21857\/mnlqgc5vgy","volume":"544","author":"S Vukicevic","year":"2020","unstructured":"Vukicevic S, Peric M, Oppermann H, Stokovic N, Ivanjko N, Erjavec I, Kufner V, Vnuk D, Bubic Spoljar J, Pecin M, Novak R, Matic Jelic I, Bakic K, Milesevic M, Rumenovic V, Popek I, Pehar S, Martinovic S, Blazevic V, Rogina L, Vikic-Topic S, Bozic T, Verbanac D, Bordukalo Niksic T, Sampath K, Pecina M, Maticic D, Grgurevic L (2020) Bone morphogenetic proteins: from discovery to development of a novel autologous bone graft substitute consisting of recombinant human BMP6 delivered in autologous blood coagulum carrier. Rad CASA - Med Sci 544:26\u201341. https:\/\/doi.org\/10.21857\/mnlqgc5vgy","journal-title":"Rad CASA - Med Sci"},{"key":"6389_CR12","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1038\/s41598-022-14931-2","volume":"12","author":"N Stokovic","year":"2022","unstructured":"Stokovic N, Ivanjko N, Pecin M, Erjavec I, Smajlovic A, Milesevic M, Karlovic S, Capak H, Vrbanac Z, Maticic D, Vukicevic S (2022) Long-term posterolateral spinal fusion in rabbits induced by rhBMP6 applied in autologous blood coagulum with synthetic ceramics. Sci Rep 12:11649. https:\/\/doi.org\/10.1038\/s41598-022-14931-2","journal-title":"Sci Rep"},{"key":"6389_CR13","doi-asserted-by":"publisher","first-page":"22079","DOI":"10.1038\/s41598-023-48878-9","volume":"13","author":"N Ivanjko","year":"2023","unstructured":"Ivanjko N, Stokovic N, Pecin M, Vnuk D, Smajlovic A, Ivkic N, Capak H, Javor A, Vrbanac Z, Maticic D, Vukicevic S (2023) Calcium phosphate ceramics combined with rhBMP6 within autologous blood coagulum promote posterolateral lumbar fusion in sheep. Sci Rep 13:22079. https:\/\/doi.org\/10.1038\/s41598-023-48878-9","journal-title":"Sci Rep"},{"key":"6389_CR14","doi-asserted-by":"publisher","first-page":"115544","DOI":"10.1016\/j.bone.2020.115544","volume":"140","author":"N Stokovic","year":"2020","unstructured":"Stokovic N, Ivanjko N, Pecin M, Erjavec I, Karlovic S, Smajlovic A, Capak H, Milosevic M, Bubic Spoljar J, Vnuk D, Maticic D, Oppermann H, Sampath TK, Vukicevic S (2020) Evaluation of synthetic ceramics as compression resistant matrix to promote osteogenesis of autologous blood coagulum containing recombinant human bone morphogenetic protein 6 in rabbit posterolateral lumbar fusion model. Bone 140:115544. https:\/\/doi.org\/10.1016\/j.bone.2020.115544","journal-title":"Bone"},{"key":"6389_CR15","doi-asserted-by":"publisher","first-page":"115844","DOI":"10.1016\/j.biopha.2023.115844","volume":"169","author":"N Ivanjko","year":"2023","unstructured":"Ivanjko N, Stokovic N, Milesevic M, Rumenovic V, Windhager R, Sampath KT, Kovacic N, Grcevic D, Vukicevic S (2023) rhBMP6 in autologous blood coagulum is a preferred osteoinductive device to rhBMP2 on bovine collagen sponge in the rat ectopic bone formation assay. Biomed Pharmacother 169:115844. https:\/\/doi.org\/10.1016\/j.biopha.2023.115844","journal-title":"Biomed Pharmacother"},{"key":"6389_CR16","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.3390\/ma14133513","volume":"14","author":"N Stokovic","year":"2021","unstructured":"Stokovic N, Ivanjko N, Maticic D, Luyten FP, Vukicevic S (2021) Bone morphogenetic proteins, carriers, and animal models in the development of Novel Bone Regenerative therapies. Materials 14:3513. https:\/\/doi.org\/10.3390\/ma14133513","journal-title":"Materials"},{"key":"6389_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bone.2014.07.010","volume":"70","author":"M Peric","year":"2015","unstructured":"Peric M, Dumic-Cule I, Grcevic D, Matijasic M, Verbanac D, Paul R, Grgurevic L, Trkulja V, Bagi CM, Vukicevic S (2015) The rational use of animal models in the evaluation of novel bone regenerative therapies. Bone 70:73\u201386. https:\/\/doi.org\/10.1016\/j.bone.2014.07.010","journal-title":"Bone"},{"key":"6389_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00264-007-0425-7","volume":"31","author":"M Pecina","year":"2007","unstructured":"Pecina M, Vukicevic S (2007) Biological aspects of bone, cartilage and tendon regeneration. Int Orthop 31:719\u2013720. https:\/\/doi.org\/10.1007\/s00264-007-0425-7","journal-title":"Int Orthop"},{"key":"6389_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00264-005-0045-z","volume":"30","author":"R Bilic","year":"2006","unstructured":"Bilic R, Simic P, Jelic M, Stern-Padovan R, Dodig D, van Meerdervoort HP, Martinovic S, Ivankovic D, Pecina M, Vukicevic S (2006) Osteogenic protein-1 (BMP-7) accelerates healing of scaphoid non-union with proximal Pole sclerosis. Int Orthop 30:128\u2013134. https:\/\/doi.org\/10.1007\/s00264-005-0045-z","journal-title":"Int Orthop"},{"key":"6389_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00264-017-3471-9","volume":"41","author":"GS Krishnakumar","year":"2017","unstructured":"Krishnakumar GS, Roffi A, Reale D, Kon E, Filardo G (2017) Clinical application of bone morphogenetic proteins for bone healing: a systematic review. Int Orthop 41:1073\u20131083. https:\/\/doi.org\/10.1007\/s00264-017-3471-9","journal-title":"Int Orthop"},{"key":"6389_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00264-007-0418-6","volume":"31","author":"WF McKay","year":"2007","unstructured":"McKay WF, Peckham SM, Badura JM (2007) A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE bone graft). Int Orthop 31:729\u2013734. https:\/\/doi.org\/10.1007\/s00264-007-0418-6","journal-title":"Int Orthop"},{"key":"6389_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s002640100262","volume":"25","author":"M Pecina","year":"2001","unstructured":"Pecina M, Giltaij LR, Vukicevic S (2001) Orthopaedic applications of osteogenic protein-1 (BMP-7). Int Orthop 25:203\u2013208. https:\/\/doi.org\/10.1007\/s002640100262","journal-title":"Int Orthop"},{"key":"6389_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00264-003-0475-4","volume":"27","author":"M Pecina","year":"2003","unstructured":"Pecina M, Haspl M, Jelic M, Vukicevic S (2003) Repair of a resistant tibial non-union with a recombinant bone morphogenetic protein-7 (rh-BMP-7). Int Orthop 27:320\u2013321. https:\/\/doi.org\/10.1007\/s00264-003-0475-4","journal-title":"Int Orthop"},{"key":"6389_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00264-020-04847-9","volume":"45","author":"N Stokovic","year":"2020","unstructured":"Stokovic N, Ivanjko N, Milesevic M, Matic Jelic I, Bakic K, Rumenovic V, Oppermann H, Shimp L, Sampath TK, Pecina M, Vukicevic S (2020) Synthetic ceramic macroporous blocks as a scaffold in ectopic bone formation induced by recombinant human bone morphogenetic protein 6 within autologous blood coagulum in rats. Int Orthop 45:1097\u20131107. https:\/\/doi.org\/10.1007\/s00264-020-04847-9","journal-title":"Int Orthop"},{"key":"6389_CR25","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00264-022-05546-3","volume":"46","author":"N Stokovic","year":"2022","unstructured":"Stokovic N, Ivanjko N, Rumenovic V, Breski A, Sampath KT, Peric M, Pecina M, Vukicevic S (2022) Comparison of synthetic ceramic products formulated with autologous blood coagulum containing rhBMP6 for induction of bone formation. Int Orthop 46:2693\u20132704. https:\/\/doi.org\/10.1007\/s00264-022-05546-3","journal-title":"Int Orthop"},{"key":"6389_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00264-007-0422-x","volume":"31","author":"AP White","year":"2007","unstructured":"White AP, Vaccaro AR, Hall JA, Whang PG, Friel BC, McKee MD (2007) Clinical applications of BMP-7\/OP-1 in fractures, nonunions and spinal fusion. Int Orthop 31:735\u2013741. https:\/\/doi.org\/10.1007\/s00264-007-0422-x","journal-title":"Int Orthop"},{"key":"6389_CR27","doi-asserted-by":"publisher","first-page":"8561","DOI":"10.1073\/pnas.0812178106","volume":"106","author":"R Berry","year":"2009","unstructured":"Berry R, Jowitt TA, Ferrand J, Roessle M, Grossmann JG, Canty-Laird EG, Kammerer RA, Kadler KE, Baldock C (2009) Role of dimerization and substrate exclusion in the regulation of bone morphogenetic protein-1 and mammalian tolloid. Proc Natl Acad Sci U S A 106:8561\u20138566. https:\/\/doi.org\/10.1073\/pnas.0812178106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6389_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.matbio.2015.02.006","volume":"44\u201346","author":"S Vadon-Le Goff","year":"2015","unstructured":"Vadon-Le Goff S, Hulmes DJ, Moali C (2015) BMP-1\/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling. Matrix Biol 44\u201346:14\u201323. https:\/\/doi.org\/10.1016\/j.matbio.2015.02.006","journal-title":"Matrix Biol"},{"key":"6389_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.200606058","volume":"175","author":"G Ge","year":"2006","unstructured":"Ge G, Greenspan DS (2006) BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol 175:111\u2013120. https:\/\/doi.org\/10.1083\/jcb.200606058","journal-title":"J Cell Biol"},{"key":"6389_CR30","doi-asserted-by":"publisher","first-page":"27051","DOI":"10.1074\/jbc.M102921200","volume":"276","author":"E Kessler","year":"2001","unstructured":"Kessler E, Fichard A, Chanut-Delalande H, Brusel M, Ruggiero F (2001) Bone morphogenetic protein-1 (BMP-1) mediates C-terminal processing of procollagen V homotrimer. J Biol Chem 276:27051\u201327057. https:\/\/doi.org\/10.1074\/jbc.M102921200","journal-title":"J Biol Chem"},{"key":"6389_CR31","doi-asserted-by":"publisher","first-page":"15842","DOI":"10.1073\/pnas.2534946100","volume":"100","author":"NM Wolfman","year":"2003","unstructured":"Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN, Wright JF, Zhao L, Sebald SM, Greenspan DS, Lee SJ (2003) Activation of latent myostatin by the BMP-1\/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A 100:15842\u201315846. https:\/\/doi.org\/10.1073\/pnas.2534946100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6389_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1124\/mol.62.1.58","volume":"62","author":"NJ Laping","year":"2002","unstructured":"Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF, Olson BA (2002) Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62:58\u201364. https:\/\/doi.org\/10.1124\/mol.62.1.58","journal-title":"Mol Pharmacol"},{"key":"6389_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/08977194.2018.1428966","volume":"35","author":"L Grgurevic","year":"2017","unstructured":"Grgurevic L, Erjavec I, Grgurevic I, Dumic-Cule I, Brkljacic J, Verbanac D, Matijasic M, Paljetak HC, Novak R, Plecko M, Bubic-Spoljar J, Rogic D, Kufner V, Pauk M, Bordukalo-Niksic T, Vukicevic S (2017) Systemic inhibition of BMP1-3 decreases progression of CCl(4)-induced liver fibrosis in rats. Growth Factors 35:201\u2013215. https:\/\/doi.org\/10.1080\/08977194.2018.1428966","journal-title":"Growth Factors"},{"key":"6389_CR34","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1681\/ASN.2010070722","volume":"22","author":"L Grgurevic","year":"2011","unstructured":"Grgurevic L, Macek B, Healy DR, Brault AL, Erjavec I, Cipcic A, Grgurevic I, Rogic D, Galesic K, Brkljacic J, Stern-Padovan R, Paralkar VM, Vukicevic S (2011) Circulating bone morphogenetic protein 1\u20133 isoform increases renal fibrosis. J Am Soc Nephrol 22:681\u2013692. https:\/\/doi.org\/10.1681\/ASN.2010070722","journal-title":"J Am Soc Nephrol"},{"key":"6389_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41467-021-27622-9","volume":"13","author":"S Vukicevic","year":"2022","unstructured":"Vukicevic S, Colliva A, Kufner V, Martinelli V, Moimas S, Vodret S, Rumenovic V, Milosevic M, Brkljacic B, Delic-Brkljacic D, Correa R, Giacca M, Maglione M, Bordukalo-Niksic T, Dumic-Cule I, Zacchigna S (2022) Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction. Nat Commun 13:81. https:\/\/doi.org\/10.1038\/s41467-021-27622-9","journal-title":"Nat Commun"},{"key":"6389_CR36","doi-asserted-by":"publisher","first-page":"C162","DOI":"10.1152\/ajpcell.00012.2020","volume":"320","author":"EN N\u2019Diaye","year":"2021","unstructured":"N\u2019Diaye EN, Cook R, Wang H, Wu P, LaCanna R, Wu C, Ye Z, Seshasayee D, Hazen M, Lin W, Tyagi T, Hotzel I, Tam L, Newman R, Roose-Girma M, Wolters PJ, Ding N (2021) Extracellular BMP1 is the major proteinase for COOH-terminal proteolysis of type I procollagen in lung fibroblasts. Am J Physiol Cell Physiol 320:C162\u2013C174. https:\/\/doi.org\/10.1152\/ajpcell.00012.2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"6389_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.matbio.2016.06.004","volume":"56","author":"AM Muir","year":"2016","unstructured":"Muir AM, Massoudi D, Nguyen N, Keene DR, Lee SJ, Birk DE, Davidson JM, Marinkovich MP, Greenspan DS (2016) BMP1-like proteinases are essential to the structure and wound healing of skin. Matrix Biol 56:114\u2013131. https:\/\/doi.org\/10.1016\/j.matbio.2016.06.004","journal-title":"Matrix Biol"},{"key":"6389_CR38","unstructured":"Stokovic N, Ivanjko N, Matic Jelic I, Milesevic M, Rumenovic V, Blazevic V, Rogina L, Bastalic I, Erjavec I, Bordukalo Niksic T, Kufner V, Adanic D, Peric M, Pecina M, Sampath K, Vukicevic S (2022) State-of-the-art of the Bone Morphogenetic Protein research field: 13th International BMP Conference, Dubrovnik 2022, Rad CASA 553 84\u201399"},{"key":"6389_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1172\/JCI3705","volume":"102","author":"W Kuang","year":"1998","unstructured":"Kuang W, Xu H, Vachon PH, Liu L, Loechel F, Wewer UM, Engvall E (1998) Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J Clin Invest 102:844\u2013852. https:\/\/doi.org\/10.1172\/JCI3705","journal-title":"J Clin Invest"},{"key":"6389_CR40","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1172\/JCI22928","volume":"114","author":"M Girgenrath","year":"2004","unstructured":"Girgenrath M, Dominov JA, Kostek CA, Miller JB (2004) Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J Clin Invest 114:1635\u20131639. https:\/\/doi.org\/10.1172\/JCI22928","journal-title":"J Clin Invest"},{"key":"6389_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0014-5793(97)01007-7","volume":"415","author":"Y Miyagoe","year":"1997","unstructured":"Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima Y, Arahata K, Nabeshima Y, Takeda S (1997) Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 415:33\u201339. https:\/\/doi.org\/10.1016\/s0014-5793(97)01007-7","journal-title":"FEBS Lett"},{"key":"6389_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ng1194-297","volume":"8","author":"H Xu","year":"1994","unstructured":"Xu H, Wu XR, Wewer UM, Engvall E (1994) Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat Genet 8:297\u2013302. https:\/\/doi.org\/10.1038\/ng1194-297","journal-title":"Nat Genet"},{"key":"6389_CR43","doi-asserted-by":"publisher","first-page":"7991","DOI":"10.1073\/pnas.0811599106","volume":"106","author":"JE Rooney","year":"2009","unstructured":"Rooney JE, Gurpur PB, Burkin DJ (2009) Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 106:7991\u20137996. https:\/\/doi.org\/10.1073\/pnas.0811599106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6389_CR44","first-page":"351","volume":"317","author":"FM Tome","year":"1994","unstructured":"Tome FM, Evangelista T, Leclerc A, Sunada Y, Manole E, Estournet B, Barois A, Campbell KP, Fardeau M (1994) Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 317:351\u2013357","journal-title":"C R Acad Sci III"},{"key":"6389_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2044-5040-4-14","volume":"4","author":"T Mehuron","year":"2014","unstructured":"Mehuron T, Kumar A, Duarte L, Yamauchi J, Accorsi A, Girgenrath M (2014) Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy. Skelet Muscle 4:14. https:\/\/doi.org\/10.1186\/2044-5040-4-14","journal-title":"Skelet Muscle"},{"key":"6389_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/JND-140042","volume":"2","author":"A Accorsi","year":"2015","unstructured":"Accorsi A, Mehuron T, Kumar A, Rhee Y, Girgenrath M (2015) Integrin dysregulation as a possible driver of matrix remodeling in laminin-deficient congenital muscular dystrophy (MDC1A). J Neuromuscul Dis 2:51\u201361","journal-title":"J Neuromuscul Dis"},{"key":"6389_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.nmd.2010.02.001","volume":"20","author":"F Geranmayeh","year":"2010","unstructured":"Geranmayeh F, Clement E, Feng LH, Sewry C, Pagan J, Mein R, Abbs S, Brueton L, Childs AM, Jungbluth H, De Goede CG, Lynch B, Lin JP, Chow G, Sousa C, O\u2019Mahony O, Majumdar A, Straub V, Bushby K, Muntoni F (2010) Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord 20:241\u2013250. https:\/\/doi.org\/10.1016\/j.nmd.2010.02.001","journal-title":"Neuromuscul Disord"},{"key":"6389_CR48","doi-asserted-by":"publisher","unstructured":"Reinhard JR, Lin S, McKee KK, Meinen S, Crosson SC, Sury M, Hobbs S, Maier G, Yurchenco PD, Ruegg MA (2017) Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice. Sci Transl Med 9. https:\/\/doi.org\/10.1126\/scitranslmed.aal4649","DOI":"10.1126\/scitranslmed.aal4649"},{"key":"6389_CR49","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1006\/bbrc.1994.1100","volume":"198","author":"S Vukicevic","year":"1994","unstructured":"Vukicevic S, Latin V, Chen P, Batorsky R, Reddi AH, Sampath TK (1994) Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes. Biochem Biophys Res Commun 198:693\u2013700. https:\/\/doi.org\/10.1006\/bbrc.1994.1100","journal-title":"Biochem Biophys Res Commun"},{"key":"6389_CR50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0092-8674(90)90176-f","volume":"63","author":"S Vukicevic","year":"1990","unstructured":"Vukicevic S, Luyten FP, Kleinman HK, Reddi AH (1990) Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin. Cell 63:437\u2013445. https:\/\/doi.org\/10.1016\/0092-8674(90)90176-f","journal-title":"Cell"},{"key":"6389_CR51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0012-1606(91)90081-d","volume":"143","author":"VM Paralkar","year":"1991","unstructured":"Paralkar VM, Vukicevic S, Reddi AH (1991) Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development. Dev Biol 143:303\u2013308. https:\/\/doi.org\/10.1016\/0012-1606(91)90081-d","journal-title":"Dev Biol"},{"key":"6389_CR52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/s0945-053x(98)90013-0","volume":"16","author":"DJ Prockop","year":"1998","unstructured":"Prockop DJ, Sieron AL, Li SW (1998) Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. Matrix Biol 16:399\u2013408. https:\/\/doi.org\/10.1016\/s0945-053x(98)90013-0","journal-title":"Matrix Biol"},{"key":"6389_CR53","doi-asserted-by":"publisher","first-page":"5596","DOI":"10.1074\/jbc.M110003200","volume":"277","author":"C Unsold","year":"2002","unstructured":"Unsold C, Pappano WN, Imamura Y, Steiglitz BM, Greenspan DS (2002) Biosynthetic processing of the pro-alpha 1(V)2pro-alpha 2(V) collagen heterotrimer by bone morphogenetic protein-1 and furin-like proprotein convertases. J Biol Chem 277:5596\u20135602. https:\/\/doi.org\/10.1074\/jbc.M110003200","journal-title":"J Biol Chem"},{"key":"6389_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1042\/BJ20030894","volume":"376","author":"RJ Medeck","year":"2003","unstructured":"Medeck RJ, Sosa S, Morris N, Oxford JT (2003) BMP-1-mediated proteolytic processing of alternatively spliced isoforms of collagen type XI. Biochem J 376:361\u2013368. https:\/\/doi.org\/10.1042\/BJ20030894","journal-title":"Biochem J"},{"issue":"Pt 1","key":"6389_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3160001","volume":"316","author":"KE Kadler","year":"1996","unstructured":"Kadler KE, Holmes DF, Trotter JA, Chapman JA (1996) Collagen fibril formation. Biochem J 316(Pt 1):1\u201311. https:\/\/doi.org\/10.1042\/bj3160001","journal-title":"Biochem J"},{"key":"6389_CR56","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1128\/MCB.25.14.5846-5858.2005","volume":"25","author":"G Ge","year":"2005","unstructured":"Ge G, Hopkins DR, Ho WB, Greenspan DS (2005) GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. Mol Cell Biol 25:5846\u20135858. https:\/\/doi.org\/10.1128\/MCB.25.14.5846-5858.2005","journal-title":"Mol Cell Biol"},{"key":"6389_CR57","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1161\/CIRCRESAHA.116.308391","volume":"118","author":"RG Walker","year":"2016","unstructured":"Walker RG, Poggioli T, Katsimpardi L, Buchanan SM, Oh J, Wattrus S, Heidecker B, Fong YW, Rubin LL, Ganz P, Thompson TB, Wagers AJ, Lee RT (2016) Biochemistry and Biology of GDF11 and myostatin: similarities, differences, and questions for Future Investigation. Circ Res 118:1125\u20131141. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308391","journal-title":"Circ Res"},{"key":"6389_CR58","doi-asserted-by":"publisher","first-page":"876078","DOI":"10.3389\/fphys.2022.876078","volume":"13","author":"MH Baig","year":"2022","unstructured":"Baig MH, Ahmad K, Moon JS, Park SY, Ho Lim J, Chun HJ, Qadri AF, Hwang YC, Jan AT, Ahmad SS, Ali S, Shaikh S, Lee EJ, Choi I (2022) Myostatin and its regulation: a Comprehensive Review of Myostatin inhibiting strategies. Front Physiol 13:876078. https:\/\/doi.org\/10.3389\/fphys.2022.876078","journal-title":"Front Physiol"},{"key":"6389_CR59","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1113\/jphysiol.2011.226001","volume":"590","author":"Q Wang","year":"2012","unstructured":"Wang Q, McPherron AC (2012) Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation. J Physiol 590:2151\u20132165. https:\/\/doi.org\/10.1113\/jphysiol.2011.226001","journal-title":"J Physiol"},{"key":"6389_CR60","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s11357-020-00279-w","volume":"42","author":"J Frohlich","year":"2020","unstructured":"Frohlich J, Vinciguerra M (2020) Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe? Geroscience 42:1475\u20131498. https:\/\/doi.org\/10.1007\/s11357-020-00279-w","journal-title":"Geroscience"},{"key":"6389_CR61","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.nmd.2012.01.010","volume":"22","author":"EM Clement","year":"2012","unstructured":"Clement EM, Feng L, Mein R, Sewry CA, Robb SA, Manzur AY, Mercuri E, Godfrey C, Cullup T, Abbs S, Muntoni F (2012) Relative frequency of congenital muscular dystrophy subtypes: analysis of the UK diagnostic service 2001\u20132008. Neuromuscul Disord 22:522\u2013527. https:\/\/doi.org\/10.1016\/j.nmd.2012.01.010","journal-title":"Neuromuscul Disord"},{"key":"6389_CR62","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awp236","volume":"132","author":"FL Norwood","year":"2009","unstructured":"Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 132:3175\u20133186. https:\/\/doi.org\/10.1093\/brain\/awp236","journal-title":"Brain"},{"key":"6389_CR63","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1093\/hmg\/ddw291","volume":"25","author":"A Accorsi","year":"2016","unstructured":"Accorsi A, Kumar A, Rhee Y, Miller A, Girgenrath M (2016) IGF-1\/GH axis enhances losartan treatment in Lama2-related muscular dystrophy. Hum Mol Genet 25:4624\u20134634. https:\/\/doi.org\/10.1093\/hmg\/ddw291","journal-title":"Hum Mol Genet"},{"key":"6389_CR64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2044-5040-2-18","volume":"2","author":"S Meinen","year":"2012","unstructured":"Meinen S, Lin S, Ruegg MA (2012) Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-alpha2-deficient congenital muscular dystrophy (MDC1A). Skelet Muscle 2:18. https:\/\/doi.org\/10.1186\/2044-5040-2-18","journal-title":"Skelet Muscle"},{"key":"6389_CR65","first-page":"139","volume":"262","author":"PK Siegl","year":"1992","unstructured":"Siegl PK, Chang RS, Mantlo NB, Chakravarty PK, Ondeyka DL, Greenlee WJ, Patchett AA, Sweet CS, Lotti VJ (1992) In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. J Pharmacol Exp Ther 262:139\u2013144","journal-title":"J Pharmacol Exp Ther"},{"key":"6389_CR66","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/jpet.109.160754","volume":"331","author":"M Erb","year":"2009","unstructured":"Erb M, Meinen S, Barzaghi P, Sumanovski LT, Courdier-Fruh I, Ruegg MA, Meier T (2009) Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency. J Pharmacol Exp Ther 331:787\u2013795. https:\/\/doi.org\/10.1124\/jpet.109.160754","journal-title":"J Pharmacol Exp Ther"},{"key":"6389_CR67","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00264-007-0407-9","volume":"31","author":"WA Grasser","year":"2007","unstructured":"Grasser WA, Orlic I, Borovecki F, Riccardi KA, Simic P, Vukicevic S, Paralkar VM (2007) BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways. Int Orthop 31:759\u2013765. https:\/\/doi.org\/10.1007\/s00264-007-0407-9","journal-title":"Int Orthop"},{"key":"6389_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13395-020-00235-4","volume":"10","author":"P Barraza-Flores","year":"2020","unstructured":"Barraza-Flores P, Hermann HJ, Bates CR, Allen TG, Grunert TT, Burkin DJ (2020) Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD. Skelet Muscle 10:18. https:\/\/doi.org\/10.1186\/s13395-020-00235-4","journal-title":"Skelet Muscle"},{"key":"6389_CR69","doi-asserted-by":"publisher","first-page":"16302","DOI":"10.1038\/s41598-018-34362-2","volume":"8","author":"CC Fontes-Oliveira","year":"2018","unstructured":"Fontes-Oliveira CC, Korner BMSO Z, V MH and, Durbeej M (2018) Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study. Sci Rep 8:16302. https:\/\/doi.org\/10.1038\/s41598-018-34362-2","journal-title":"Sci Rep"}],"container-title":["International Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-024-06389-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00264-024-06389-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-024-06389-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T07:09:07Z","timestamp":1736147347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00264-024-06389-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["6389"],"URL":"https:\/\/doi.org\/10.1007\/s00264-024-06389-w","relation":{},"ISSN":["0341-2695","1432-5195"],"issn-type":[{"type":"print","value":"0341-2695"},{"type":"electronic","value":"1432-5195"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"S.V. is the inventor of the following patents related to the anti-fibrotic effect of BMP1.3 issued to the School of Medicine University of Zagreb: US 7850964, JP 5016041, AU 2007275580, EP2518496, CA 2658582; JP 6133402, New Zealand 631639. The other authors do not have any competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}